NCT06588101 Clinical Trial Recruitment and Retention Strategies for Family Members in the ICU
| NCT ID | NCT06588101 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Lady Davis Institute |
| Condition | Family Members |
| Study Type | INTERVENTIONAL |
| Enrollment | 160 participants |
| Start Date | 2024-05-01 |
| Primary Completion | 2026-04-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 160 participants in total. It began in 2024-05-01 with a primary completion date of 2026-04-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
There is a need to identify strategies that improve the conduct of clinical trials involving family members of intensive care unit (ICU) patients. The purpose of the present study is to evaluate recruitment and retention strategies for clinical trials involving family members of ICU patients. 4 strategies (2 recruitment and 2 retention) will be tested. Investigators will integrate the strategies into three existing studies that involve family members of ICU patients. Participants will be randomized using a 2x2 factorial design. The co-primary outcomes are recruitment percentage (participants enrolled/participants approached) and retention percentage (participants completing follow-up/participants enrolled).
Eligibility Criteria
Inclusion Criteria: * Has family member admitted to an intensive care unit. * Expected hospital stay \> 48 hours * Able to participate in English or French Exclusion Criteria: * Has another family member participating in the trial * Repeat admissions within the study period
Contact & Investigator
Michael J Goldfarb, MD, MSc
PRINCIPAL INVESTIGATOR
Lady Davis Institute, McGill University, Jewish General Hospital
Frequently Asked Questions
Who can join the NCT06588101 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Family Members. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06588101 currently recruiting?
Yes, NCT06588101 is actively recruiting participants. Contact the research team at jillian.kifell.ccomtl@ssss.gouv.qc.ca for enrollment information.
Where is the NCT06588101 trial being conducted?
This trial is being conducted at Montreal, Canada.
Who is sponsoring the NCT06588101 clinical trial?
NCT06588101 is sponsored by Lady Davis Institute. The principal investigator is Michael J Goldfarb, MD, MSc at Lady Davis Institute, McGill University, Jewish General Hospital. The trial plans to enroll 160 participants.